Brest, France

Karine Le Ny

This inventor holds 1 USPTO granted patent. Top assignees: Centre Hospitalier Universitaire De Brest, Centre National De La Recherche Scientifique, National Institute of Health and Medical Research. Active years: 2010.


Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Karine Le Ny: Innovator in Lipophilic Compounds

Introduction

Karine Le Ny is a notable inventor based in Brest, France. She has made significant contributions to the field of chemistry, particularly in the development of lipophilic compounds. Her work has implications in various applications, showcasing her innovative spirit and dedication to research.

Latest Patents

Karine Le Ny holds a patent for "Lipophilic compounds and uses thereof." This invention involves a cationic lipophilic compound represented by a specific general formula. The patent highlights her expertise in creating compounds that can be utilized in various scientific and medical applications. She has 1 patent to her name, reflecting her impactful contributions to the field.

Career Highlights

Throughout her career, Karine has worked with prestigious institutions such as the Centre National de la Recherche Scientifique and the National Institute of Health and Medical Research. These experiences have allowed her to collaborate with leading experts in her field and contribute to groundbreaking research.

Collaborations

Karine has collaborated with notable colleagues, including Hervé Des Abbayes and Jean-Jacques Yaouanc. These partnerships have enriched her research and expanded the scope of her innovations.

Conclusion

Karine Le Ny is a distinguished inventor whose work in lipophilic compounds has made a significant impact in her field. Her dedication to research and collaboration with esteemed institutions and colleagues underscores her role as a leading innovator.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…